Virtual musculoskeletal (MSK) care provider Sword Health has secured USD 130 million in a funding round, bringing the total funds raised by the company to USD 340 million. This funding round also values the company at USD 3 billion, marking a 50% increase from its Series D valuation.

The funding round comprises a secondary sale of USD 100 million, aimed at providing liquidity for current and former employees and early investors. Additionally, a primary sale of USD 30 million is designated to expand its AI-based solution, AI Care, into new markets and categories.

Further, Sword Health introduced Phoenix, an AI-based care specialist designed to interact with patients and guide them during sessions. It features natural conversation, real-time feedback, and clinical analysis, helping clinicians optimize patient progression. Phoenix will be integrated across the Sword platform, starting with Thrive for physical pain and then into Bloom for women’s pelvic health.